Skip to main content

Table 3 SIRs of second primary cancer by type of first primary cancer and sex

From: The relative risk of second primary cancers in Austria’s western states: a retrospective cohort study

Sex Males Females
First primary cancer Obs. SIR (95% CI) Obs. SIR (95% CI)
Head/Neck/Larynx 281 1.88 (1.67–2.11) 53 1.74 (1.30–2.28)
Stomach 111 0.94 (0.77–1.13) 57 0.83 (0.63–1.07)
Colon/Rectum 381 0.91 (0.82–1.00) 233 0.89 (0.78–1.01)
Lung 130 0.90 (0.75–1.06) 56 1.58 (1.19–2.05)
Melanoma 133 0.93 (0.78–1.10) 107 0.94 (0.77–1.14)
Breast    580 0.82 (0.75–0.89)
Cervix    102 1.40 (1.14–1.70)
Endometrium    177 1.08 (0.92–1.25)
Ovary    72 1.09 (0.85–1.37)
Prostate 1117 0.68 (0.64–0.72)   
Bladder 300 1.20 (1.07–1.34) 61 1.13 (0.86–1.45)
Kidney 162 1.22 (1.04–1.42) 84 1.29 (1.03–1.59)
Thyroid gland 40 1.23 (0.88–1.67) 79 1.40 (1.11–1.75)
NHL high/low 68 1.20 (0.93–1.53) 43 1.23 (0.89–1.66)
CLL/ALL 34 0.93 (0.64–1.30) 22 1.11 (0.69–1.67)
All cancers combined 3036 0.90 (0.86–0.93) 1913 1.00 (0.96–1.05)
All cancers except Prostate 1919 1.10 (1.05–1.15)   
  1. Obs. Observed number of second primary cancers, SIR standardized incidence ratio, CI confidence interval, NHL non-Hodgkin Lymphoma, CLL chronic lymphatic leukaemia, ALL acute lymphatic leukaemia
  2. SIRs shown in normal bold font indicate significantly increased risk, SIRs shown in bold italics indicate significantly decreased risk